May 20-25, 2012 - Albufeira, Portugal

Editors:   B. Buckland, University College London, UK
  J. Aunins, Janis Biologics, LLC
  P. Alves , ITQB/IBET
  K. Jansen, Wyeth Vaccine Research

The articles for these proceedings are not peer-reviewed.

Follow

PDF

Conference Program, Engineering Conferences International (Conference Proceeding)

PDF

Comprehensive T cell antigen discovery using a genomic approach, Jessica Baker (Conference Proceeding)

PDF

Rational design of a fully synthetic nanoparticle-based vaccine for smoking cessatio, Takashi Kishimoto (Conference Proceeding)

PDF

Tolerogenic Vaccination Exploiting Apoptotic Mechanisms via Erythrocyte-to- Hepatic/Splenic Targeting, Jeffrey Hubbell (Conference Proceeding)

PDF

Development of a Vaccine Against Clostridium difficile Infection (CDI): Design, Purification, and Biological Activities of the Recombinant Toxin 1 Antigens, Jerzy Karczewski (Conference Proceeding)

PDF

111 years producing immunobiologicals: New challenges, Jorge Kalil (Conference Proceeding)

PDF

Bringing Vaccine Manufacturing Capabilities to the Developing World, George Robertson (Conference Proceeding)

PDF

Recombinant VLP based human vaccines for emerging markets, Qinjian Zhao (Conference Proceeding)

PDF

Establishing human vaccine manufacturing in Southern Africa, Morena Makhoana (Conference Proceeding)

PDF

Recombinant influenza vaccine, Manon Cox (Conference Proceeding)

PDF

Process understanding approach for a late-stage recombinant protein vaccine produced in Saccharomyces Cerevisiae, Jose Manuel Otero, Brian Mickus, Amanda Schallop, Brian Doyle, and Nedim Altaras (Conference Proceeding)

PDF

Challenges in development of an anti-idiotypic cancer vaccine, Adolfo Castillo (Conference Proceeding)

PDF

Expectation of China's contribution to world vaccine development and supplies: Status, strategy and international approach, Li Shi (Conference Proceeding)

PDF

Rabies virus-like particles expressed in HEK293 cells, Diego Fontana, Ricardo Kratje, Marina Etcheverrigaray, and Claudio Prieto (Conference Proceeding)

PDF

The role of public-private partnerships in advancing vaccine technologies and improving vaccine effectiveness and delivery for developing countries, Ray Cummings (Conference Proceeding)

PDF

Challenges in Batch Production of Malaria Vaccines, Nicolas Havelange (Conference Proceeding)

PDF

Formulation and Stability of a Chikungunya Virus-Like Particle (ChikV VLP) Based Vaccine, Rhicard Schwartz (Conference Proceeding)

PDF

High throughput formulation design for a stable lyophilized virus-like particle vaccine against Group A Streptococcu, Yap Chuan (Conference Proceeding)

PDF

Challenges in Optimizing Formulations for Multi- Antigen Vaccines, Lakshmi Khandke (Conference Proceeding)

PDF

A Protein-Free Process and Product Protection System, Stephen Ward (Conference Proceeding)

PDF

A new successful vaccine against babesiosis: Any use for malaria?, Thep Schetters (Conference Proceeding)

PDF

Leishmaniasis vaccine development: Animals as models and patients, Steven Reid (Conference Proceeding)

PDF

Rift valley fever: Next generation vaccines for an old foe, Brian Bird (Conference Proceeding)

PDF

Functional genomics as a tool to define a molecular signature of effective vaccination against foot and mouth disease virus, Jose Chabalgoity (Conference Proceeding)

PDF

Oncolytic viruses as cancer therapies, Stephen Rusell (Conference Proceeding)

PDF

The CMC challenges in Developing an Oncolytic Immunotherapy, Colin Love (Conference Proceeding)

PDF

Process Development for a Peptide Conjugated QbetaVirus Like Particle (VLP) Vaccine, Jennifer Thorn (Conference Proceeding)

PDF

Chimpanzee ad vector technology platform for prophylactic and therapeutic genetic vaccine applications, Stefano Colloca (Conference Proceeding)

PDF

Cervical cancer immunotherapy: Induction of HPV specific CTLs in human volunteers after VGX-3100 immunization, Niranjan Sardesai (Conference Proceeding)

PDF

Microbial fermentation: New tools to speed-up vaccine antigen development and increase process knowledge, Catherine Jourdat (Conference Proceeding)

PDF

Bacterial expression of a VLP Sub-unit for rapid and cheap influenza vaccination, Anton Middelberg (Conference Proceeding)

PDF

High cell density cultivations for influenza virus production using suspension cells, Y. Genzel, T. Vogel, J. Buck, I. Behrendt, G. Schiedner, I. Jordan, and U. Reichl (Conference Proceeding)

PDF

RMCE-based Sf9 cell factory for production of multi-meric VLPs, Ana Teixera (Conference Proceeding)

PDF

Systematically Characterizing Adventitious Agent Tests for Biologics, Rebecca Sheets (Conference Proceeding)

PDF

Automation and multiplexing of immunoassays: Improving precision and throughput, Ilia Tikhonov (Conference Proceeding)

PDF

Developing a Suite of Analytics to Support Process Development for the Manufacture of Polysaccharides, Aaron Noyes, Ranga Godavarti, Nigel Titchener-Hooker, Jonathan Coffman, and Tarit Mukhopadhyay (Conference Proceeding)

PDF

Building Pandemic Preparedness Through a Sustainable Enterprise for Influenza Vaccines, Robert Huebner (Conference Proceeding)

PDF

Bacterium-like particles as delivery vehicles for multimeric antigens, Kees Leenhouts (Conference Proceeding)

PDF

Mutiply activated VLP influenza vaccines, James Swartz, Yuan Lu, John Welsh, and Wei Chan (Conference Proceeding)

PDF

Endotoxin-free E. Coli hosts for vaccine discovery and production, David Bramhill (Conference Proceeding)

PDF

Novel glycoconjugate vaccines based on rationally designed synthetic carbohydrate antigens, Stwewart Campbell (Conference Proceeding)

PDF

Utilizing ‘omics tools to investigate the impact of process changes on product quality in cell culture-based influenza vaccine production, E. Rapp, J. Rodig, J. Schwarzer, D. Hoeper, R. Hennig, Y. Genzel, and U. Reichl (Conference Proceeding)

PDF

Monolithic Columns for Purification and In-process Control of Viruses and Virus-like Particles, Lidija Urbas and Milos Barut (Conference Proceeding)

PDF

Plant-Made Influenza Virus-Like Particles: for Pandemic and Beyond, Nathalie Charland (Conference Proceeding)

PDF

Flunisyn: Advanced development of a synthetic universal influenza t-cell vaccine, Campbell Bunce (Conference Proceeding)

PDF

Purification of cell-based influenza H5N1 viruses by liquid chromatography technologies, Alan Yung-Chih Hu (Conference Proceeding)

PDF

Viral sensitizer technology improves yield of modified vaccinia ankara from available cell substrates, Facrice Le Boeuf (Conference Proceeding)

PDF

Suspension Vero cells (sVERO) for poliovirus production: Effect of culture passage on growth kinetics and productivity, Guillermina Forno (Conference Proceeding)